These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 19450725)

  • 1. The improbable plunge. What facts refute reasons to expect that the effectiveness of HPV vaccination programs to prevent cervical cancer could be low?
    Porta M
    Prev Med; 2009 May; 48(5):407-10. PubMed ID: 19450725
    [No Abstract]   [Full Text] [Related]  

  • 2. Public health issues related to HPV vaccination.
    Hershey JH; Velez LF
    J Public Health Manag Pract; 2009; 15(5):384-92. PubMed ID: 19704306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HPV vaccination.
    Brotherton J
    Aust Fam Physician; 2007 Jun; 36(6):391; author reply 391. PubMed ID: 17582901
    [No Abstract]   [Full Text] [Related]  

  • 4. The epidemiology behind the HPV vaccine discovery.
    Koutsky L
    Ann Epidemiol; 2009 Apr; 19(4):239-44. PubMed ID: 19344861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implementation of the Australian HPV vaccination program for adult women: qualitative key informant interviews.
    Leask J; Jackson C; Trevena L; McCaffery K; Brotherton J
    Vaccine; 2009 Sep; 27(40):5505-12. PubMed ID: 19619501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attitudes toward HPV vaccination among parents of adolescent girls in Mysore, India.
    Madhivanan P; Krupp K; Yashodha MN; Marlow L; Klausner JD; Reingold AL
    Vaccine; 2009 Aug; 27(38):5203-8. PubMed ID: 19596420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating human papillomavirus vaccination programs.
    Donovan B; Guy RJ
    Sex Transm Dis; 2013 Apr; 40(4):290-1. PubMed ID: 23481536
    [No Abstract]   [Full Text] [Related]  

  • 8. Challenges, lessons learned and results following the implementation of a human papilloma virus school vaccination program in South Australia.
    Watson M; Shaw D; Molchanoff L; McInnes C
    Aust N Z J Public Health; 2009 Aug; 33(4):365-70. PubMed ID: 19689598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Details of HPV immunisation need not delay decision.
    Finn A
    BMJ; 2005 Nov; 331(7524):1081. PubMed ID: 16269500
    [No Abstract]   [Full Text] [Related]  

  • 10. Data are still needed for HPV immunisation programme.
    Gill ON; Lowndes CM
    BMJ; 2005 Nov; 331(7526):1204. PubMed ID: 16293856
    [No Abstract]   [Full Text] [Related]  

  • 11. [Introduction of vaccination against human papillomavirus in developing countries: update and perspectives].
    Hessel L
    Med Trop (Mars); 2009 Aug; 69(4):323-6. PubMed ID: 19725378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health systems and immunization financing for human papillomavirus vaccine introduction in low-resource settings.
    Biellik R; Levin C; Mugisha E; LaMontagne DS; Bingham A; Kaipilyawar S; Gandhi S
    Vaccine; 2009 Oct; 27(44):6203-9. PubMed ID: 19698808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrating human papillomavirus vaccination in cervical cancer control programmes.
    Franco EL; Coutlée F; Ferenczy A
    Public Health Genomics; 2009; 12(5-6):352-61. PubMed ID: 19684447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of prevention education on Human Papillomavirus linked to cervix cancer for unmarried female university students].
    Kim HW
    J Korean Acad Nurs; 2009 Aug; 39(4):490-8. PubMed ID: 19726905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of human papillomavirus infections and associated diseases by vaccination: a new hope for global public health.
    Harper DM
    Public Health Genomics; 2009; 12(5-6):319-30. PubMed ID: 19684444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness analysis: an essential tool to inform public health policy in cervical cancer prevention.
    Franco EL; Drummond MF
    Vaccine; 2008 Sep; 26 Suppl 5():F1-2. PubMed ID: 18992378
    [No Abstract]   [Full Text] [Related]  

  • 17. Hear all about it: nightly television news coverage of cervical cancer vaccination in the United States.
    Wallace LS; Ache KA
    J Low Genit Tract Dis; 2009 Jul; 13(3):154-8. PubMed ID: 19550212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short version of the German evidence-based Guidelines for prophylactic vaccination against HPV-associated neoplasia.
    Pathirana D; Hillemanns P; Petry KU; Becker N; Brockmeyer NH; Erdmann R; Gissmann L; Grundhewer H; Ikenberg H; Kaufmann AM; Klusmann J; Kopp I; Pfister H; Rzany B; Schneede P; Schneider A; Smola S; Winter-Koch N; Wutzler P; Gross G
    Vaccine; 2009 Jul; 27(34):4551-9. PubMed ID: 19524337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness analysis of a cervical cancer vaccine in five Latin American countries.
    Colantonio L; Gómez JA; Demarteau N; Standaert B; Pichón-Rivière A; Augustovski F
    Vaccine; 2009 Sep; 27(40):5519-29. PubMed ID: 19616499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A scientific response to prevent cervical cancer in the world.
    Bosch FX
    Vaccine; 2008 Aug; 26 Suppl 12():v-vi. PubMed ID: 18945420
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.